Literature DB >> 17562991

Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.

Chao Li1, Zhong Huang, Ronald Kingsley, Xiaohong Zhou, Feng Li, David W Parke, Wei Cao.   

Abstract

OBJECTIVE: To identify and characterize biochemical alterations in the retinas of very low-density lipoprotein receptor (VLDLr) knockout mice in an animal model of retinal angiomatous proliferation.
METHODS: Immunohistochemical analysis, Western blot analysis, reverse transcriptase-polymerase chain reaction, and electrophoretic mobility shift assay were used to identify and characterize the altered gene and protein expression as well as signal cascades involved in the pathogenesis of neovascularization in the retinas of VLDLr mice.
RESULTS: Expression of the angiogenic factors vascular endothelial growth factor and basic fibroblast growth factor was significantly greater in the lesion area, and Müller cells around the lesion area were activated, as indicated by increased expression of glial fibrillary acidic protein. Expression of the proinflammatory cytokine IL-18 (interleukin 18) and the inflammation mediator intercellular adhesion molecule-1 was increased before significant intraretinal neovascularization. Furthermore, phosphorylation of Akt and mitogen-activated protein kinase and translocalization of nuclear factor kappa B were greater in VLDLr knockout mouse retinas.
CONCLUSION: An inflammatory process is involved in the development of neovascularization in the VLDLr knockout mouse retina. CLINICAL RELEVANCE: Understanding the molecular mechanisms underlying these biochemical alterations in the retinas of VLDLr knockout mice will provide a foundation for developing novel therapeutic approaches to retinal angiomatous proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562991     DOI: 10.1001/archopht.125.6.795

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  29 in total

1.  Congruence of vascular network remodeling and neuronal dispersion in the hippocampus of reelin-deficient mice.

Authors:  Tina Lindhorst; Haymo Kurz; Mirjam Sibbe; Maurice Meseke; Eckart Förster
Journal:  Histochem Cell Biol       Date:  2012-01-20       Impact factor: 4.304

2.  Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.

Authors:  Jing Hua; Karen I Guerin; Jing Chen; Shaday Michán; Andreas Stahl; Nathan M Krah; Molly R Seaward; Roberta J Dennison; Aimee M Juan; Colman J Hatton; Przemyslaw Sapieha; David A Sinclair; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

3.  The role of Vldlr in intraretinal angiogenesis in mice.

Authors:  Chun-Hong Xia; Eric Lu; Haiquan Liu; Xin Du; Bruce Beutler; Xiaohua Gong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-22       Impact factor: 4.799

4.  Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway.

Authors:  Xue Cai; Sudipta Seal; James F McGinnis
Journal:  Biomaterials       Date:  2013-10-18       Impact factor: 12.479

5.  Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina.

Authors:  Julia V Busik; Maria B Grant
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-05       Impact factor: 8.311

Review 6.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

7.  Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction.

Authors:  Norihiro Nagai; Pete Lundh von Leithner; Kanako Izumi-Nagai; Brett Hosking; Bo Chang; Ron Hurd; Peter Adamson; Anthony P Adamis; Richard H Foxton; Yin Shan Ng; David T Shima
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

Review 8.  Ocular neovascularization.

Authors:  Peter A Campochiaro
Journal:  J Mol Med (Berl)       Date:  2013-01-18       Impact factor: 4.599

9.  Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.

Authors:  Michael I Dorrell; Edith Aguilar; Ruth Jacobson; Oscar Yanes; Ray Gariano; John Heckenlively; Eyal Banin; G Anthony Ramirez; Mehdi Gasmi; Alan Bird; Gary Siuzdak; Martin Friedlander
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

10.  Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency.

Authors:  Ying Chen; Yang Hu; Gennadiy Moiseyev; Kevin K Zhou; Danyang Chen; Jian-xing Ma
Journal:  Microvasc Res       Date:  2009-03-10       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.